Related Experiment Video

Updated: Aug 16, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy

Oliver Zimmermann1, Matthias Kochs, Thomas Paul Zwaka

  • 1Department of Internal Medicine II-Cardiology, University of Ulm, Robert-Koch-Str. 8, 89081 Ulm, Germany. oliver.zimmermann@medizin.uni-ulm.de

International Journal of Cardiology
|September 3, 2005
PubMed

Insights

Inflammatory cardiomyopathy, identified through myocardial biopsy, showed the best patient outcomes. Targeted anti-inflammatory or antiviral treatments may improve results for non-responsive heart failure patients.

Area of Science:

  • Cardiology
  • Immunology
  • Virology

Background:

  • Dilated cardiomyopathy (DCM) presents a significant challenge in cardiovascular medicine.
  • The role of myocardial inflammation and viral infections in DCM prognosis remains incompletely understood.

Purpose of the Study:

  • To investigate the correlation between myocardial biopsy findings (inflammation, viral presence) and clinical outcomes in patients with dilated cardiomyopathy.
  • To evaluate the efficacy of specific treatments (interferon beta1b, prednisolone) in patient subgroups.

Main Methods:

  • Myocardial biopsies from 82 DCM patients were analyzed for inflammatory markers (HLAI, HLAII, CD54, CD2, CD68) and viruses (entero-/adenovirus).
  • Ejection fraction, NYHA classification, ECG, and echocardiography were assessed at baseline and follow-up.
  • Patients were categorized into three groups: no inflammation/no virus (A), inflammation/no virus (B), and virus with/without inflammation (C).

Main Results:

  • Enterovirus was the only detected virus. Group B (inflammation/no virus) had worse initial ejection fraction than Group A (p=0.003).
  • Groups A and B demonstrated significant improvements in echocardiography and NYHA classification (p<0.001).
  • Group B showed superior outcomes in echocardiography (p=0.014) and NYHA classification (p=0.023) compared to Group A, suggesting inflammatory cardiomyopathy has a better prognosis.

Conclusions:

  • Myocardial inflammation, independent of viral detection, is associated with a favorable prognosis in dilated cardiomyopathy.
  • Anti-inflammatory or antiviral therapies represent a potential therapeutic strategy for refractory heart failure patients with specific myocardial findings.
Abstract

More Related Videos

3D Whole-heart Myocardial Tissue Analysis06:53

3D Whole-heart Myocardial Tissue Analysis

Published on: April 12, 2017

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...